Contribution of oxidative metabolism to cocaine-induced liver and kidney damage

Current Medicinal Chemistry

Volumn 19, Issue 33, 2012, Pages 5601-5606

  Valente, M J ^a   Carvalho, F ^a   Bastos, M D L ^a   De Pinho, P G ^a   Carvalho, M ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSIDADE FERNANDO PESSOA   (Portugal)

Author keywords

Cocaine; Kidney; Liver; Metabolism; Oxidative stress; Toxicity

Indexed keywords

ANTIOXIDANT; COCAINE; CYTOCHROME P450; NORCOCAINE; REACTIVE OXYGEN METABOLITE;

AEROBIC METABOLISM; ARTICLE; COCAINE DEPENDENCE; HUMAN; KIDNEY INJURY; LIVER INJURY; LIVER TOXICITY; NEPHROTOXICITY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REACTION ANALYSIS;

ANIMALS; COCAINE; DOPAMINE UPTAKE INHIBITORS; HUMANS; KIDNEY; LIVER; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84871305067     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803988938     Document Type: Article

References (71)

1. UNODC: World Drug Report 2011. United Nations Publication 2011, Sales No. E.10. XI.10.
2. Aslibekyan S, Levitan EB, Mittleman MA: Prevalent cocaine use and myocardial infarction. Am J Cardiol 2008, 102(8):966-969.
3. Goldstein RA, Des Lauriers C, Burda AM: Cocaine: history, social implications, and toxicity-a review. Dis Mon 2009, 55(1):6-38.
4. Haim D Y, Lippmann ML, Goldberg SK, Walkenstein MD: The pulmonary complications of crack cocaine. A comprehensive review. Chest 1995, 107(1):233-240.
5. Lucena J, Blanco M, Jurado C, Rico A, Salguero M, Vazquez R, Thiene G, Basso C: Cocaine-related sudden death: a prospective investigation in southwest Spain. Eur Heart J, 31(3):318-329.
6. Wanless IR, Dore S, Gopinath N, Tan J, Cameron R, Heathcote EJ, Blendis LM, Levy G: Histopathology of cocaine hepatotoxicity. Report of four patients. Gastroenterology 1990, 98(2):497-501.
7. Lombard J, Wong B, Young JH: Acute renal failure due to rhabdomyolysis associated with cocaine toxicity. West J Med 1988, 148(4):466-468.
8. Glauser J, Queen JR: An overview of non-cardiac cocaine toxicity. J Emerg Med 2007, 32(2):181-186.
9. Dinis-Oliveira RJ, Carvalho F, Duarte JA, Proenca JB, Santos A, Magalhaes T: Clinical and forensic signs related to cocaine abuse. Curr Drug Abuse Rev 2012, 5(1):64-83.
10. Ritz MC, George FR: Cocaine toxicity: concurrent influence of dopaminergic, muscarinic and sigma receptors in mediating cocaine-induced lethality. Psychopharmacology (Berl) 1997, 129(4):311-321.
11. Kanel GC, Cassidy W, Shuster L, Reynolds TB: Cocaine-induced liver cell injury: comparison of morphological features in man and in experimental models. Hepatology 1990, 11(4):646-651.
12. Harris DS, Everhart ET, Mendelson J, Jones RT: The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug Alcohol Depend 2003, 72(2):169-182.
13. Hearn WL, Rose S, Wagner J, Ciarleglio A, Mash DC: Cocaethylene is more potent than cocaine in mediating lethality. Pharmacol Biochem Behav 1991, 39(2):531-533.
14. Laizure SC, Mandrell T, Gades NM, Parker RB: Cocaethylene metabolism and interaction with cocaine and ethanol: role of carboxylesterases. Drug Metab Dispos 2003, 31(1):16-20.
15. Wu AH, Onigbinde TA, Johnson KG, Wimbish GH: Alcohol-specific cocaine metabolites in serum and urine of hospitalized patients. J Anal Toxicol 1992, 16(2):132-136.
16. Jacob P, 3rd, Lewis ER, Elias-Baker BA, Jones RT: A pyrolysis product, anhydroecgonine methyl ester (methylecgonidine), is in the urine of cocaine smokers. J Anal Toxicol 1990, 14(6):353-357.
17. Kintz P, Sengler C, Cirimele V, Mangin P: Evidence of crack use by anhydroecgonine methylester identification. Hum Exp Toxicol 1997, 16(2):123-127.
18. Fandino AS, Toennes SW, Kauert GF: Studies on hydrolytic and oxidative metabolic pathways of anhydroecgonine methyl ester (methylecgonidine) using microsomal preparations from rat organs. Chem Res Toxicol 2002, 15(12):1543-1548.
19. Kloss M W, Rosen GM, Rauckman EJ: N-demethylation of cocaine to norcocaine. Evidence for participation by cytochrome P-450 and FAD-containing monooxygenase. Mol Pharmacol 1983, 23(2):482-485.
20. Le Duc BW, Sinclair PR, Shuster L, Sinclair JF, Evans JE, Greenblatt DJ: Norcocaine and N-hydroxynorcocaine formation in human liver microsomes: role of cytochrome P-450 3A4. Pharmacology 1993, 46(5):294-300.
21. Dean RA, Harper ET, Dumaual N, Stoeckel DA, Bosron WF: Effects of ethanol on cocaine metabolism: formation of cocaethylene and norcocaethylene. Toxicol Appl Pharmacol 1992, 117(1):1-8.
22. Maurer HH, Sauer C, Theobald DS: Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine. Ther Drug Monit 2006, 28(3):447-453.
23. Ndikum-Moffor FM, Schoeb TR, Roberts SM: Liver toxicity from norcocaine nitroxide, an N-oxidative metabolite of cocaine. J Pharmacol Exp Ther 1998, 284(1):413-419.
24. Evans MA, Harbison RD: Cocaine-induced hepatotoxicity in mice. Toxicol Appl Pharmacol 1978, 45(3):739-754.
25. Mehanny SZ, Abdel-Rahman MS: Cocaine hepatotoxicity in mice: histologic and enzymatic studies. Toxicol Pathol 1991, 19(1):24-29.
26. Watanabe HK, Hoskins B, Ho IK: Sensitivity difference to hepatotoxicity of cocaine in spontaneously hypertensive and Wistar Kyoto rats. Alcohol Drug Res 1987, 7(5-6):363-370.
27. Gubbins G P, Schiffman RM, Alapati RS, Batra SK: Cocaine-induced hepatonephrotoxicity: a case report. Henry Ford Hosp Med J 1990, 38(1):55-56.
28. Perino LE, Warren GH, Levine JS: Cocaine-induced hepatotoxicity in humans. Gastroenterology 1987, 93(1):176-180.
29. Boelsterli UA, Goldlin C: Biomechanisms of cocaine-induced hepatocyte injury mediated by the formation of reactive metabolites. Arch Toxicol 1991, 65(5):351-360.
30. Pellinen P, Honkakoski P, Stenback F, Niemitz M, Alhava E, Pelkonen O, Lang MA, Pasanen M: Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors. Eur J Pharmacol 1994, 270(1):35-43.
31. Thompson ML, Shuster L, Shaw K: Cocaine-induced hepatic necrosis in mice-the role of cocaine metabolism. Biochem Pharmacol 1979, 28(15):2389-2395.
32. Aoki K, Takimoto M, Ota H, Yoshida T: Participation of CYP2A in cocaineinduced hepatotoxicity in female mice. Pharmacol Toxicol 2000, 87(1):26-32.
33. Bornheim LM: Effect of cytochrome P450 inducers on cocaine-mediated hepatotoxicity. Toxicol Appl Pharmacol 1998, 150(1):158-165.
34. Pellinen P, Stenback F, Kojo A, Honkakoski P, Gelboin H V, Pasanen M: Regenerative changes in hepatic morphology and enhanced expression of CYP2B10 and CYP3A during daily administration of cocaine. Hepatology 1996, 23(3):515-523.
35. Boelsterli UA, Lanzotti A, Goldlin C, Oertle M: Identification of cytochrome P-450IIB1 as a cocaine-bioactivating isoform in rat hepatic microsomes and in cultured rat hepatocytes. Drug Metab Dispos 1992, 20(1):96-101.
36. Poet TS, Brendel K, Halpert JR: Inactivation of cytochromes P450 2B protects against cocaine-mediated toxicity in rat liver slices. Toxicol Appl Pharmacol 1994, 126(1):26-32.
37. Poet TS, McQueen CA, Halpert JR: Participation of cytochromes P4502B and P4503A in cocaine toxicity in rat hepatocytes. Drug Metab Dispos 1996, 24(1):74-80.
38. Li A P, Kaminski DL, Rasmussen A: Substrates of human hepatic cytochrome P450 3A4. Toxicology 1995, 104(1-3):1-8.
39. Connors S, Rankin DR, Gandolfi AJ, Krumdieck CL, Koep LJ, Brendel K: Cocaine hepatotoxicity in cultured liver slices: a species comparison. Toxicology 1990, 61(2):171-183.
40. Benuck M, Reith ME, Sershen H, Wiener HL, Lajtha A: Oxidative metabolism of cocaine: comparison of brain and liver. Proc Soc Exp Biol Med 1989, 190(1):7-13.
41. Rauckman EJ, Rosen GM, Cavagnaro J: Norcocaine nitroxide. A potential hepatotoxic metabolite of cocaine. Mol Pharmacol 1982, 21(2):458-463.
42. Rosen GM, Kloss MW, Rauckman EJ: Initiation of in vitro lipid peroxidation by N-hydroxynorcocaine and norcocaine nitroxide. Mol Pharmacol 1982, 22(3):529-531.
43. Donnelly DA, Boyer CS, Petersen DR, Ross D: Cocaine-induced biochemical changes and cytotoxicity in hepatocytes isolated from both mice and rats. Chem Biol Interact 1988, 67(1-2):95-104.
44. Ponsoda X, Bort R, Jover R, Gomez-Lechon MJ, Castell JV: Increased toxicity of cocaine on human hepatocytes induced by ethanol: role of GSH. Biochem Pharmacol 1999, 58(10):1579-1585.
45. Jover R, Ponsoda X, Gomez-Lechon MJ, Herrero C, del Pino J, Castell JV: Potentiation of cocaine hepatotoxicity by ethanol in human hepatocytes. Toxicol Appl Pharmacol 1991, 107(3):526-534.
46. Zaragoza A, Diez-Fernandez C, Alvarez AM, Andres D, Cascales M: Effect of N-acetylcysteine and deferoxamine on endogenous antioxidant defense system gene expression in a rat hepatocyte model of cocaine cytotoxicity. Biochim Biophys Acta 2000, 1496(2-3):183-195.
47. Labib R, Abdel-Rahman MS, Turkall R: N-acetylcysteine pretreatment decreases cocaine and endotoxin-induced hepatotoxicity. J Toxicol Environ Health A 2003, 66(3):223-239.
48. Boyer CS, Petersen DR: Potentiation of cocaine-mediated hepatotoxicity by acute and chronic ethanol. Alcohol Clin Exp Res 1990, 14(1):28-31.
49. Devi BG, Chan AW: Cocaine-induced peroxidative stress in rat liver: antioxidant enzymes and mitochondria. J Pharmacol Exp Ther 1996, 279(1):359-366.
50. Masini A, Gallesi D, Giovannini F, Trenti T, Ceccarelli D: Membrane potential of hepatic mitochondria after acute cocaine administration in rats - the role of mitochondrial reduced glutathione. Hepatology 1997, 25(2):385-390.
51. Diez-Fernandez C, Zaragoza A, Alvarez AM, Cascales M: Cocaine cytotoxicity in hepatocyte cultures from phenobarbital-induced rats: involvement of reactive oxygen species and expression of antioxidant defense systems. Biochem Pharmacol 1999, 58(5):797-805.
52. Boelsterli UA, Wolf A, Goldlin C: Oxygen free radical production mediated by cocaine and its ethanol-derived metabolite, cocaethylene, in rat hepatocytes. Hepatology 1993, 18(5):1154-1161.
53. Aoki K, Ohmori M, Takimoto M, Ota H, Yoshida T: Cocaine-induced liver injury in mice is mediated by nitric oxide and reactive oxygen species. Eur J Pharmacol 1997, 336(1):43-49.
54. Evans MA: Role of protein binding in cocaine-induced hepatic necrosis. J Pharmacol Exp Ther 1983, 224(1):73-79.
55. Charkoudian JC, Shuster L: Electrochemistry of norcocaine nitroxide and related compounds: implications for cocaine hepatotoxicity. Biochem Biophys Res Commun 1985, 130(3):1044-1051.
56. Bouis P, Boelsterli UA: Modulation of cocaine metabolism in primary rat hepatocyte cultures: effects on irreversible binding and protein biosynthesis. Toxicol Appl Pharmacol 1990, 104(3):429-439.
57. Boess F, Ndikum-Moffor FM, Boelsterli UA, Roberts SM: Effects of cocaine and its oxidative metabolites on mitochondrial respiration and generation of reactive oxygen species. Biochem Pharmacol 2000, 60(5):615-623.
58. Devi BG, Chan AW: Impairment of mitochondrial respiration and electron transport chain enzymes during cocaine-induced hepatic injury. Life Sci 1997, 60(11):849-855.
59. Boyer CS, Petersen DR: Hepatic biochemical changes as a result of acute cocaine administration in the mouse. Hepatology 1991, 14(6):1209-1216.
60. Leon-Velarde F, Huicho L, Monge C: Effects of cocaine on oxygen consumption and mitochondrial respiration in normoxic and hypoxic mice. Life Sci 1992, 50(3):213-218.
61. Cascales M, Alvarez A, Gasco P, Fernandez-Simon L, Sanz N, Bosca L: Cocaine-induced liver injury in mice elicits specific changes in DNA ploidy and induces programmed death of hepatocytes. Hepatology 1994, 20(4 Pt 1):992-1001.
62. Gitman MD, Singhal PC: Cocaine-induced renal disease. Expert Opin Drug Saf 2004, 3(5):441-448.
63. Madhrira MM, Mohan S, Markowitz GS, Pogue VA, Cheng JT: Acute bilateral renal infarction secondary to cocaine-induced vasospasm. Kidney Int 2009, 76(5):576-580.
64. Merigian KS, Roberts JR: Cocaine intoxication: hyperpyrexia, rhabdomyolysis and acute renal failure. J Toxicol Clin Toxicol 1987, 25(1-2):135-148.
65. Garcia-Rostan y Perez GM, Garcia Bragado F, Puras Gil AM: Pulmonary hemorrhage and antiglomerular basement membrane antibody-mediated glomerulonephritis after exposure to smoked cocaine (crack): a case report and review of the literature. Pathol Int 1997, 47(10):692-697.
66. Alvarez D, Nzerue CM, Daniel JF, Faruque S, Hewan-Lowe K: Acute interstitial nephritis induced by crack cocaine binge. Nephrol Dial Transplant 1999, 14(5):1260-1262.
67. Bemanian S, Motallebi M, Nosrati SM: Cocaine-induced renal infarction: report of a case and review of the literature. BMC Nephrol 2005, 6:10.
68. Peces R, Navascues RA, Baltar J, Seco M, Alvarez J: Antiglomerular basement membrane antibody-mediated glomerulonephritis after intranasal cocaine use. Nephron 1999, 81(4):434-438.
69. Barroso-Moguel R, Mendez-Armenta M, Villeda-Hernandez J: Experimental nephropathy by chronic administration of cocaine in rats. Toxicology 1995, 98(1-3):41-46.
70. Valente MJ, Henrique R, Vilas-Boas V, Silva R, Bastos Mde L, Carvalho F, Guedes de Pinho P, Carvalho M: Cocaine-induced kidney toxicity: an in vitro study using primary cultured human proximal tubular epithelial cells. Arch Toxicol 2012, 86(2):249-261.
71. Schaaf GJ, de Groene EM, Maas RF, Commandeur JN, Fink-Gremmels J: Characterization of biotransformation enzyme activities in primary rat proximal tubular cells. Chem Biol Interact 2001, 134(2):167-190.